Yuko Okuyama
Diagnostic R&D
Osaka, Japan
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
2-Azanorbornane-Based Amino Amide Organocatalysts for Asymmetric Michael Addition of β-Keto Esters with Nitroolefins.
Journal: Chemical & pharmaceutical bulletin
Published: July 09, 2025
Supersulfide controls intestinal inflammation by suppressing CD4+ T cell proliferation.
Journal: Frontiers in immunology
Published: October 05, 2024
Naturally Arising Memory-Phenotype CD4+ T Lymphocytes Give Rise to Multiple Helper Subsets to Contribute to Tumor Immunity while Inhibiting GVHD.
Journal: Cancer immunology research
Published: June 27, 2024
Thiourea fused γ-amino alcohol organocatalysts for asymmetric Mannich reaction of β-keto active methylene compounds with imines.
Journal: RSC advances
Published: December 30, 2022
OX40 Ligand-Mannose-Binding Lectin Fusion Protein Induces Potent OX40 Cosignaling in CD4+ T Cells.
Journal: Biological & pharmaceutical bulletin
Published: November 30, 2022
IL-33-ILC2 axis promotes anti-tumor CD8+ T cell responses via OX40 signaling.
Journal: Biochemical and biophysical research communications
Published: October 18, 2022
New small γ-turn type N-primary amino terminal tripeptide organocatalyst for solvent-free asymmetric aldol reaction of various ketones with aldehydes.
Journal: RSC advances
Published: November 25, 2021
TNF Receptor-Associated Factor 5 Limits IL-27 Receptor Signaling in CD4+ T Lymphocytes.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 02, 2020
Phenotypic heterogeneity in individuals with MECOM variants in 2 families.
Journal: Blood advances
Published: November 23, 2020
Dysregulation of Rnf 213 gene contributes to T cell response via antigen uptake, processing, and presentation.
Journal: Journal of cellular physiology
Published: October 23, 2020
Last Updated: 09/26/2026